U.S. federal trademark · Serial No. 86031758
Pharmaceutical preparations for the treatment of catastrophic diseases, namely, focal segmental glomerulosclerosis, pantothenate kinase-associated neurodegeneration, duchenne muscular dystrophy and spinal muscular atrophy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.